An interesting example of the hypocrisy of groups like the National Organization for Women is its recent public opposition to the possible re-introduction of silicone breast implants. NOW argues that there is not enough long term data to justify saying that silicone breast implants are safe, but NOW’s real objection seems to be that silicone breast implants are not politically correct enough.
There are plenty of long-term studies of the effects of silicone breast implants in women who had them before the FDA’s temporary ban on the implants — almost all of which found that there simply were no adverse health risks associated with implants. The concerns that implants increased the risk of breast cancer or contributed to chronic diseases of the early 1990s turned out to be simple hysteria.
But nonetheless, NOW President Kim Gandy complaints that the FDA is only reviewing two years wroth of data and, “Two years of data is not going to give you any valid information so that women will know what’s going into their bodies.”
Nonsense. In this case NOW has simply stooped to the level of its anti-abortion opponents who used and continue to use exactly this argument against both oral contraceptives and abortion-inducing drugs such as RU-486. In fact when the FDA dragged its feet on approving RU-486, it was Gandy who was whining about excessive bureaucracy and overblown concerns about a drug that had proven safe through decades of use elsewhere in the world. As Gandy put it in a NOW press release,
It’s all too typical that our U.S. bureaucracy would take this important medical advancement for women and make it as difficult as possible for us to take advantage of its full potential.
If only makers of silicone breast implants could find a way to make them have some sort of contraceptive or abortion abilities as well, perhaps they would be politically correct enough for NOW to stop its ridiculous attempt to prevent women from making their own private health choices about implants.
Groups oppose allowing silicone breast implants. Lisa Richwine, Reuters, July 21, 2003.
NOW Members Call for FDA Approval of Mifepristone (RU-486) for Abortion, Cancer and Other Treatments. Press Release, National Organization for Women, Summer 2000.